Patent Assignment
Reel/Frame 064313/0444
Assignment of Assignor's Interest
Recorded: 2023-07-19
Pages: 9
Assignor
ALTAVANT SCIENCES GMBH
Executed: 2023-05-17
Assignee
ONSPIRA THERAPEUTICS, INC.
640 LEE ROAD, SUITE 117, WAYNE, PENNSYLVANIA, 19087
Covered Properties
(21)
Compositions of Interleukin-1 Receptor Antagonist
PCT:
PCT/US2022/025738 ↗
Rhinosinusitis Prevention and Therapy with Proinflammatory Cytokine Inhibitors
Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors
Localized Therapy of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors
Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors
Compositions of Interleukin-1 Receptor Antagonist
Application:
17/726,164 →
Publication:
US 2022/0339099
Treatment of Lower Airways Disorders
Application:
17/781,289 →
Publication:
US 2022/0409627
An Inhaled Il-1 Blockade Treatment for Respiratory Tract Immunopathology
Application:
17/926,297 →
Publication:
US 2023/0210768
Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors
Application:
18/330,588 →
Publication:
US 2024/0084306
Rhinosinusitis therapy with proinflammatory cytokine inhibitors
Application:
60/819,703 →
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
Application:
60/836,760 →
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
Application:
60/878,385 →
Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
Application:
60/878,397 →
Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
Application:
60/907,027 →
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
Application:
60/907,028 →
Treatment of Lower Airways Disorders
Application:
62/942,424 →
Compositions of Interleukin-1 Receptor Antagonist
Application:
62/985,167 →
Compositions of Interleukin-1 Receptor Antagonist
Application:
63/106,097 →
Compositions of Interleukin-1 Receptor Antagonist
Application:
63/178,062 →
Compositions of Interleukin-1 Receptor Antagonist
Application:
63/244,807 →
IL-1 Receptor Antagonist Treatment for Neutrophilic Lung Disease
Application:
63/413,502 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 31, 2013
From: ARUBOR CORPORATION
To: LEVITT, ROY C.
Reel/Frame 031525/0295 →
Assignment of Assignor's Interest
Dec 12, 2013
From: ARUBOR CORPORATION
To: LEVITT, ROY C.
Reel/Frame 031776/0423 →
Security Agreement
Jun 26, 2017
From: LEVITT, ROY, DR.; LEVITT, MARCIA
To: SOLOMON, RAY
Reel/Frame 042992/0064 →
Release of Security Interest
Jan 13, 2020
From: SOLOMON, RAY
To: LEVITT, ROY; LEVITT, MARCIA
Reel/Frame 051492/0896 →
Assignment of Assignor's Interest
Jan 13, 2020
From: LEVITT, ROY; LEVITT, MARCIA
To: ONSPIRA THERAPEUTICS INC.
Reel/Frame 051492/0911 →
Assignment of Assignor's Interest
Jan 22, 2021
From: BARANOWSKI, LYN A.; BISHOP, JAMES P.; SYMONDS, WILLIAM T.
To: ALTAVANT SCIENCES GMBH
Reel/Frame 055005/0679 →
Assignment of Assignor's Interest
Jan 22, 2021
From: LORTIE, BRIAN A.; KILGORE, KENNETH S.
To: ONSPIRA THERAPEUTICS, INC.
Reel/Frame 055005/0799 →
Assignment of Assignor's Interest
Mar 9, 2021
From: LEVITT, ROY, DR.
To: ONSPIRA THERAPEUTICS, INC.
Reel/Frame 055539/0433 →
Assignment of Assignor's Interest
Mar 9, 2021
From: ONSPIRA THERAPEUTICS, INC.
To: ALTAVANT SCIENCES GMBH
Reel/Frame 055539/0791 →
Assignment of Assignor's Interest
Oct 6, 2021
From: WRING, STEPHEN A.; HASTEDT, JAYNE E.; CRIZER, KATELYN R.; PALACIOS, MICHELLE
To: ALTAVANT SCIENCES GMBH
Reel/Frame 057711/0193 →
Assignment of Assignor's Interest
Oct 7, 2021
From: WRING, STEPHEN A.; HASTEDT, JAYNE E.; CRIZER, KATELYN R.; PALACIOS, MICHELLE
To: ALTAVANT SCIENCES GMBH
Reel/Frame 057734/0815 →
Assignment of Assignor's Interest
Oct 11, 2021
From: WRING, STEPHEN A.; HASTEDT, JAYNE E.; CRIZER, KATELYN R.; PALACIOS, MICHELLE
To: ALTAVANT SCIENCES GMBH
Reel/Frame 057754/0842 →
Assignment of Assignor's Interest
Jul 19, 2023
From: ENZYVANT THERAPEUTICS, INC.
To: ALTAVANT SCIENCES GMBH
Reel/Frame 064310/0422 →
Assignment of Assignor's Interest
Jul 19, 2023
From: LEVITT, ROY C.
To: ARUBOR CORPORATION
Reel/Frame 064311/0208 →
Assignment of Assignor's Interest
Jul 19, 2023
From: LEVITT, ROY C.
To: ARUBOR CORPORATION
Reel/Frame 064311/0260 →
Assignment of Assignor's Interest
Jul 19, 2023
From: LEVITT, ROY C.
To: ARUBOR CORPORATION
Reel/Frame 064311/0301 →
Assignment of Assignor's Interest
Jul 19, 2023
From: ARUBOR CORPORATION
To: LEVITT, ROY C.
Reel/Frame 064311/0342 →
Assignment of Assignor's Interest
Jul 19, 2023
From: LEVITT, ROY C.
To: ARUBOR CORPORATION
Reel/Frame 064311/0433 →
Assignment of Assignor's Interest
Jul 19, 2023
From: LEVITT, ROY C.
To: ARUBOR CORPORATION
Reel/Frame 064311/0636 →
Assignment of Assignor's Interest
Jul 19, 2023
From: ARUBOR CORPORATION
To: LEVITT, ROY C.
Reel/Frame 064311/0758 →
Assignment of Assignor's Interest
Jul 19, 2023
From: LEVITT, ROY, DR.
To: ONSPIRA THERAPEUTICS, INC.
Reel/Frame 064312/0261 →
Assignment of Assignor's Interest
Jul 19, 2023
From: ONSPIRA THERAPEUTICS, INC.
To: ALTAVANT SCIENCES GMBH
Reel/Frame 064312/0770 →
Assignment of Assignor's Interest
Jul 19, 2023
From: ENZYVANT THERAPEUTICS, INC.
To: ALTAVANT SCIENCES GMBH
Reel/Frame 064312/0961 →
Corrective Assignment to Correct the Filing Dates Listed on "Exhibit a" of Assiggnment Previously Recorded at Reel: 055539 Frame: 0433. Assignor(S) Hereby Confirms the Assignment.
Jul 19, 2023
From: LEVITT, ROY, DR.
To: ONSPIRA THERAPEUTICS, INC.
Reel/Frame 064339/0319 →
Corrective Assignment to Correct the Filing Dates Listed on "Exhibit a" of Assignment Previously Recorded at Reel: 055539 Frame: 0791. Assignor(S) Hereby Confirms the Assignment.
Jul 19, 2023
From: ONSPIRA THERAPEUTICS, INC.
To: ALTAVANT SCIENCES GMBH
Reel/Frame 064340/0068 →